Big Move For Actinium Pharmaceuticals, Inc.
Wed, Sep 15, 2021 at 05:30 PM
Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT) shot up at $6.83, representing a gain of 18.6%. On Tue, Sep 14, 2021, ATNM:NYSEMKT hit a New 2-Week Low of $5.76. The stock appeared on our News Catalysts scanner on Wed, Sep 15, 2021 at 07:22 AM in the 'BIOTECH' category. From Tue, Aug 31, 2021, the stock recorded 22.22% Up Days and 20.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.
Top 10 Gainers:
- GreenSky, Inc. (GSKY:NASDAQ), 53.15%
- INDP (INDP:NASDAQ), 52.05%
- Blue Apron Holdings, Inc. (APRN:NYSE), 44.59%
- IRNT (IRNT:NYSE), 37.78%
- Sphere 3D Corp. (ANY:NASDAQ), 26.07%
- UROY (UROY:NASDAQ), 25.35%
- Marine Products Corporation (MPX:NYSE), 20.78%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 18.75%
- Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT), 18.58%
- Till Capital Ltd. (TIL:NASDAQ), 16.55%